January - March 2021

Surgical Management Of Severe Ar Following Candida Aortic Valve Endocarditis

Kumar Aditya1*, Tushar Kumar2, Harpreet Singh Minhas3

1,2MBBS, MS (general surgery), Senior Resident, 3MBBS, MS (general surgery), MCh (Cardiothoracic and vascular surgery - CTVS Director Professor and HOD, Cardiothoracic and Vascular Surgery (CTVS), G. B. Pant Hospital (GBPH), New Delhi, India



BACKGROUND: Infective endocarditis (IE) remains a dangerous condition with unchanging incidence and a mortality approaching 30% at 1 year.1Surgery is potentially lifesaving2and  required in 25% to 50% of cases during acute infection and 20% to 40% during convalescence.3–5Operative procedures are often technically difficult and associated with high risk. The most frequent indications are congestive heart failure (60%), refractory sepsis (40%), embolic complications (18%), and vegetation size (48%), with a combination of these factors being present in many patients.7 Overall surgical mortality in active IE is 6% to 25%, with long-term survival rates of approximately 70% in most series.3–5.We present a case report of severe AR following candida aortic valve endocarditis  who was successfully treated with aortic valve replacement. The purpose of this paper is to discuss about an extremely rare pathology and to highlight favorable results of the treatment used, despite the limited experience in the literature


Keywords: fungal endocarditis, vegetations, aortic valve replacement


Keywords: Severe Ar Following Candida Aortic Valve Endocarditis

[Full Text Article]